CCRA Clinical Trial Monitoring Techniques 1 — Questions and Answers
Question 1: What is the primary objective of a Site Initiation Visit (SIV)?
- To collect final data and close the site
- To train site staff and confirm readiness to enroll subjects (Correct answer)
- To resolve outstanding data queries
- To audit financial records
Correct answer: To train site staff and confirm readiness to enroll subjects
The SIV ensures that site staff are adequately trained on the protocol, procedures, and GCP requirements, and that all essential documents and supplies are in place before enrollment begins.
Question 2: Risk-Based Monitoring (RBM) focuses monitoring resources primarily on:
- Sites with the highest enrollment numbers
- Identified critical data and processes with the greatest patient risk potential (Correct answer)
- Regulatory submission timelines
- Sites closest geographically to the sponsor
Correct answer: Identified critical data and processes with the greatest patient risk potential
RBM, as endorsed by ICH E6(R2) and FDA guidance, prioritizes monitoring efforts based on identified risks to subject safety and data integrity rather than routine 100% source data verification.
Question 3: Source Data Verification (SDV) involves comparing CRF data to:
- The protocol
- Original source documents such as medical records and lab reports (Correct answer)
- The investigator brochure
- The monitoring report
Correct answer: Original source documents such as medical records and lab reports
SDV is the process of comparing data recorded in the CRF or EDC system against the original source documents to confirm accuracy, completeness, and consistency.
Question 4: A Monitoring Visit Report (MVR) must be completed and submitted to the sponsor within the timeframe specified in the monitoring plan primarily to:
- Bill the site for monitoring costs
- Document visit findings and ensure timely follow-up on issues identified (Correct answer)
- Satisfy enrollment quotas
- Archive IRB correspondence
Correct answer: Document visit findings and ensure timely follow-up on issues identified
The MVR documents all findings, actions taken, and required follow-up items to ensure issues are tracked to resolution and the sponsor maintains oversight of site compliance.
Question 5: During a monitoring visit, a CRA finds a discrepancy between the CRF and source data. The FIRST action should be:
- Correct the CRF entry directly
- Request a query be raised and ask site staff to correct the CRF with explanation (Correct answer)
- Remove the subject from the dataset
- Immediately report to the FDA
Correct answer: Request a query be raised and ask site staff to correct the CRF with explanation
Discrepancies should be resolved through the formal query process so that any CRF corrections are made by authorized site staff with appropriate documentation and explanation.
Question 6: What is the purpose of a Pre-Study Visit (PSV) or Site Qualification Visit (SQV)?
- To conduct final data lock activities
- To assess the site's suitability, resources, and investigator qualifications before trial startup (Correct answer)
- To re-consent subjects following a protocol amendment
- To perform a closeout audit
Correct answer: To assess the site's suitability, resources, and investigator qualifications before trial startup
The PSV/SQV evaluates whether the site has the required patient population, qualified personnel, facilities, and investigator commitment to conduct the trial successfully.
CCRA Clinical Trial Monitoring Techniques 1
What is the primary objective of a Site Initiation Visit (SIV)?